Search

everythinglearnresearchcommunity

for

Search:↓

The protein interleukin-1 alpha helps regenerate hair follicles and increase stem cell growth in mice.

Interleukin-15 can help hair growth and protect hair follicles.

Terbinafine effectively treated kerion celsi despite disrupted immune responses.

A 44-year-old woman with Down's syndrome was diagnosed with both rheumatoid and gouty arthritis and treated with multiple medications.

Treatment improved PCOS symptoms and reduced BMI and certain immune factors.

Wound healing can help prevent hair loss from chemotherapy in young rats by increasing interleukin-1β signaling.

3D cell cultures are better for testing hair growth treatments than 2D cultures.

High YKL-40 levels predict early hair loss and hidden metabolic issues.

TLR4 is important in aging-related diseases and could be a new treatment target.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

A new cosmetic cream reduced facial redness and skin temperature after 4 weeks of use.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Apremilast did not work for treating severe alopecia areata.

New acne treatments show promise as alternatives to traditional therapies.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

Garden cress extract may help treat skin inflammation and androgen-related disorders.

Probiotic bacteria improved skin and hair health in aged mice.

New liposomal formulations may improve delivery of treatments to hair follicles, potentially helping with hair loss.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Apremilast shows promise for several skin conditions but needs more research.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Women with PCOS, especially those overweight, have higher levels of IL-18 in their endometrium, which may affect fertility.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.